Hemodynamic derangement and cardiac dysfunction in cirrhosis

Paolo Gentilini1, Giorgio La Villa, Giacomo Laffi

  • 1Dipartimento di Medicina Interna, Università degli Studi di Firenze. p.gentilini@dmi.unifi.it

Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna
|August 20, 2004
PubMed

Insights

Early diuretic use in liver cirrhosis may reverse cardiac dysfunction. This treatment aids in managing fluid balance and improving circulation in patients with advanced liver disease.

Area of Science:

  • Hepatology
  • Cardiology
  • Nephrology

Background:

  • Liver cirrhosis is a chronic disease with a long progression, often marked by complications.
  • Hemodynamic alterations, including sodium retention and ascites, are key complications in cirrhosis.
  • Understanding these hemodynamic changes is crucial for effective disease management.

Purpose of the Study:

  • To elucidate the distinct stages of hemodynamic modifications in liver cirrhosis.
  • To investigate the impact of early diuretic intervention on cardiac function in cirrhotic patients.

Main Methods:

  • The study describes two stages of hemodynamic changes in cirrhosis.
  • Focuses on the effects of early administration of diuretics, specifically antialdosteronics.

Main Results:

  • The first stage involves water and sodium accumulation, increased plasma flow, vascular instability, and hyperdynamic circulation.
  • The second stage is characterized by modified and profoundly altered cardiac function.
  • Early diuretic use demonstrated potential to reverse cardiac dysfunction by increasing diuresis and natriuresis and decreasing plasma volume.

Conclusions:

  • Hemodynamic modifications in liver cirrhosis progress through identifiable stages.
  • Early intervention with diuretics, such as antialdosteronics, can positively impact cardiac function and fluid balance.
  • This approach may help restore physiological status in patients with liver cirrhosis and associated complications.

Related Concept Videos

Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...